Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Jasper Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.jaspertherapeutics.comThe seat is still open. No replacement has been named 16 days after this filing.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Jasper Therapeutics' CFO Herb Cross resigned effective October 9, 2026, prompting the board to appoint interim replacements across financial and corporate governance roles. This leadership transition creates near-term uncertainty around financial oversight and strategic direction during a critical period for the biotech company.
Key Takeaways
Herb Cross resigned from CFO, Principal Financial Officer, Principal Accounting Officer, and Corporate Secretary roles due to other professional pursuits
Jeet Mahal (President and CEO) assumed interim Principal Financial Officer duties, creating dual responsibilities at the executive level
2 more takeaways
Filing Overview
What This Means
Jasper Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.